All articles by GlobalData Healthcare

ASH 2025: J&J’s Tecvayli + Darzale set to redefine early relapse MM

At the American Society of Hematology (ASH) Annual Meeting 2025, held in Orlando, Florida, from 6 to 9 December, updated…
ASH 2025: AbbVie and Genmab’s Epkinly sets new standard in second-line FL

At the American Society of Hematology (ASH) Annual Meeting, held on 6-9 December, results from the global, multicentre, open-label, randomised,…
ASH 2025: Eli Lilly’s Jaypirca emerges as a strong first-line contender in CLL/SLL

At the American Society of Hematology (ASH) Annual Meeting, held on 6-9 December updated results from the global, multi-centre, open-label,…
Brazilian study links postnatal rapid weight gain to elevated paediatric BMI

Rapid weight gain in early life is a well-documented risk factor for childhood obesity, as well as the onset of…
New HBV vaccine guidance likely to increase infection among newborns

The US Advisory Committee on Immunization Practices (ACIP) has voted to recommend delaying the hepatitis B virus (HBV) vaccination administered…

ASH 2025: potential new BCL2 inhibitor option for R/R CLL

At the 2025 American Society of Hematology (ASH) Congress, held on 5-9 December, results from a Phase II pivotal study…
ASH 2025: Arcellx and Gilead’s Anito-cel challenges CAR-T market in R/R MM

At the American Society of Hematology (ASH) Annual Meeting 2025, held in Orlando, Florida and online from 7 to 10…
Chronic hepatitis B therapeutics market to reach $3.2bn across 7MM in 2034

The CHB therapeutics market across the 7MM, comprising the US, 5EU, and Japan, is forecast to grow from $1.5bn in…
CKD-HPT, HP and HK market to reach $4bn across 7MM by 2034

The chronic kidney disease (CKD)-hyperparathyroidism (HPT), hyperphosphatemia (HP) and hyperkalemia (HK) market is poised to grow at a compound annual…
7MM autism spectrum disorder market to reach $2bn by 2034

The autism spectrum disorder (ASD) market across the seven major markets (7MM: France, Germany, Italy, Japan, Spain, the UK and…